Literature DB >> 31283229

Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.

Meng-Chen Lu1,2, Xian Zhang1,2, Feng Wu1, Shi-Jie Tan1, Jing Zhao1, Qi-Dong You1,2, Zheng-Yu Jiang1,2.   

Abstract

The transcription factor Nrf2 is a key regulator of cytoprotective system, and enhancing Nrf2 activity can protect cells from various insults and threats. Directly disrupting Keap1-Nrf2 protein-protein interactions has been regarded as a promising way to activate Nrf2. We reported here the first identification of amino acids as preferred substituents to design potent Keap1-Nrf2 inhibitors. Comprehensive structure-activity analysis identified Pro as a preferred substituent, obtaining a potent inhibitor 35 with an IC50 of 43 nM in the competitive fluoresce polarization (FP) assay and a Kd value of 53.7 nM for Keap1 protein in the isothermal titration calorimetry (ITC) assay. The Pro analogue 35 exhibited tight and prolonged Keap1 binding in vitro and in cells, and treatment with 35 activated Nrf2-regulated cytoprotective response and antagonized acetaminophen-induced liver injury both in cellular and in vivo models. This work not only provides a useful tool to further explore the therapeutic potential of Keap1-Nrf2 inhibition but also enriches the diversity of chemical structures suitable for the Keap1-Nrf2 interface.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31283229     DOI: 10.1021/acs.jmedchem.9b00818

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.

Authors:  L K Kadian; M Arora; C P Prasad; R Pramanik; S S Chauhan
Journal:  Clin Transl Oncol       Date:  2022-01-06       Impact factor: 3.405

2.  Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors.

Authors:  Phillip R Lazzara; Atul D Jain; Amanda C Maldonado; Benjamin Richardson; Kornelia J Skowron; Brian P David; Zamia Siddiqui; Kiira M Ratia; Terry W Moore
Journal:  ACS Med Chem Lett       Date:  2020-02-19       Impact factor: 4.345

3.  Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction.

Authors:  Sumi Lee; Longqin Hu
Journal:  Med Chem Res       Date:  2020-04-10       Impact factor: 1.965

4.  ZJ01, a Small Molecule Inhibitor of the Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction, Reduces Hyperoxic Acute Lung Injury in a Mouse Model.

Authors:  Jun Wan; Shaoyan Lin; Xiuling Huang; Qianqin Li; Lingjun Zeng; Song Du
Journal:  Med Sci Monit       Date:  2020-05-21

5.  Transition Metal-Free N-Arylation of Amino Acid Esters with Diaryliodonium Salts.

Authors:  Gabriella Kervefors; Leonard Kersting; Berit Olofsson
Journal:  Chemistry       Date:  2021-03-03       Impact factor: 5.236

6.  The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2.

Authors:  Sharadha Dayalan Naidu; Takafumi Suzuki; Dina Dikovskaya; Elena V Knatko; Maureen Higgins; Miu Sato; Miroslav Novak; José A Villegas; Terry W Moore; Masayuki Yamamoto; Albena T Dinkova-Kostova
Journal:  iScience       Date:  2021-12-27

7.  Hepatocyte-Specific Deficiency of DAX-1 Protects Mice from Acetaminophen-Induced Hepatotoxicity by Activating NRF2 Signaling.

Authors:  Young-Joo Suh; Hyo-Jeong Yun; Yu-Bin Kim; Eun-Jung Kang; Jung Hyeon Choi; Young-Keun Choi; In-Bok Lee; Dong-Hee Choi; Yun Jeong Seo; Jung-Ran Noh; Jong-Soo Lee; Yong-Hoon Kim; Chul-Ho Lee
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 8.  Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.

Authors:  Chung-Hang Leung; Jia-Tong Zhang; Guan-Jun Yang; Hao Liu; Quan-Bin Han; Dik-Lung Ma
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

9.  Identification of New Targets and the Virtual Screening of Lignans against Alzheimer's Disease.

Authors:  Mayara Dos Santos Maia; Gabriela Cristina Soares Rodrigues; Natália Ferreira de Sousa; Marcus Tullius Scotti; Luciana Scotti; Francisco Jaime B Mendonça-Junior
Journal:  Oxid Med Cell Longev       Date:  2020-08-15       Impact factor: 6.543

10.  A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1-Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury.

Authors:  Guodong Li; Hao Liu; Ruibing Feng; Tian-Shu Kang; Wanhe Wang; Chung-Nga Ko; Chun-Yuen Wong; Min Ye; Dik-Lung Ma; Jian-Bo Wan; Chung-Hang Leung
Journal:  Redox Biol       Date:  2021-09-10       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.